Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Methylphenidate DAT occupancy SPECT study in adults with ADHD with or without cocaine dependence
NL-OMON26472Recruiting
- Sponsor
- Crunelle CL, Booij J, Van den Brink W
- Start
- Jan 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label trial of methylphenidate in attention deficit hyperactivity disorder (ADHD) and cocaine use disorder (CUD) (2 arms), sponsored by Crunelle CL, Booij J, Van den Brink W. Primary endpoints: Striatal dopamine transporter occupancy, ADHD symptoms and 3 more. Started Jan 2009; status: recruiting.
02
Drugs
methylphenidate
03
Conditions
attention deficit hyperactivity disorder (ADHD)cocaine use disorder (CUD)
Beyond the preview
Go deeper on NL-OMON26472.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON26472.